Skip to main navigation Skip to search Skip to main content

Carbapenem-resistant Gram-negative bacilli infections in Japanese patients with cancer

  • Naoya Itoh
  • , Takanori Kawabata
  • , Nana Akazawa
  • , Kayoko Hayakawa
  • , Masahiro Suzuki
  • , Aki Sakurai
  • , Kohei Uemura
  • , Yasufumi Matsumura
  • , Ryota Hase
  • , Hideaki Kato
  • , Takehiro Hashimoto
  • , Takashi Matono
  • , David van Duin
  • , Norio Ohmagari
  • , Yohei Doi
  • , Sho Saito

Research output: Contribution to journal › Article › peer-review

Abstract

Carbapenem-resistant bacteria represent a significant challenge for patients with cancer; however, the characteristics and prognoses of carbapenem-resistant Gram-negative bacilli (CRGNB) infections in Japanese patients with cancer remain unclear. Therefore, we aimed to investigate the features and outcomes of CRGNB infections in this population. This multicenter prospective observational cohort study prospectively enrolled 167 patients with CRGNB infections, with or without cancer from April 2019 to March 2022. The 30-day mortality rate was numerically higher, although not significantly (18.2% vs. 14.0%, p = 0.45), in the cancer group than in the non-cancer group. The average length of hospital stay was similar (44.6 days vs. 51.0 days, p = 0.55). Similarly, the incidence of the composite outcome—defined as the 30-day mortality or events associated with worsening clinical course—was also not significantly different (56.1% vs. 43.6%, p = 0.12). Propensity score analysis using inverse probability weighting showed no significant difference in the 30-day mortality and average length of hospital stay (p = 0.25 and 0.66). However, the incidence of the composite outcome was significantly higher in the cancer group (odds ratio, 2.36; p = 0.02). Patients with cancer and CRGNB infection experienced worse composite outcomes than those without cancer, highlighting the need for preventive measures for CRGNB infections in this population.

Original languageEnglish
Article number23572
JournalScientific reports
Volume16
Issue number1
DOIs
Publication statusPublished - 12-2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • General

Fingerprint

Dive into the research topics of 'Carbapenem-resistant Gram-negative bacilli infections in Japanese patients with cancer'. Together they form a unique fingerprint.

Cite this